SciQuus Study Presented at the 2024 ASCO Gastrointestinal Cancers Symposium in San Francisco

SciQuus Study Presented at the 2024 ASCO Gastrointestinal Cancers Symposium in San Francisco

SciQuus is pleased to be included as authors on the following presentation at he 2024 ASCO GI Cancer Symposium:

“BNT321, a novel monoclonal antibody targeting sialyl Lewis A: Phase 1 monotherapy and combination with mFOLFIRINOX in patients with advanced CA19-9 expressing cancers.”

The presented was Eileen O’Reilly from the Memorial Sloan Kettering Cancer Center in New York.

More SciQuus News